Advertisement

Low expression of excision repair cross-complementation group-1 protein predicts better outcome in patients with locally advanced nasopharyngeal cancer treated with concurrent chemoradiotherapy

Abstract

Aims and background. Cisplatin-based concurrent chemoradiotherapy is the standard treatment of locally advanced nasopharyngeal cancer. We conducted this study to assess the value of excision repair cross-complementation group 1 (ERCC1) protein expression in predicting the clinical outcome of patients with locally advanced nasopharyngeal cancer who were treated with cisplatin-based concurrent chemoradiotherapy.
Methods and study design. We employed immunohistochemical analysis to determine the expression of ERCC1 protein among 66 patients with locally advanced nasopharyngeal cancer who were treated with concurrent chemoradiotherapy. The relationship of ERCC1 expression to clinical outcome was analyzed.
Results. There were no statistically significant differences in gender, age, T stage, N stage, clinical staging and treatment method between the high ERCC1 expression and low ERCC1 expression groups. Fifty-eight patients (87.88%) had a complete response and 8 (12.12%) a partial response. Of the 34 patients with high ERCC1 expression, 10 (29.41%) relapsed, compared with 4 of 32 (12.5%) patients with low ERCC1 expression (P = 0.041). The 5-year overall survival rate was 58.82% in patients with high ERCC1 expression and 84.37% in patients with low ERCC1 expression (P = 0.022). Multivariate analysis showed that low expression of ERCC1 was a significant independent prognostic factor for better overall survival (P = 0.026).
Conclusions. Low ERCC1 expression is associated with prolonged survival in patients with locally advanced nasopharyngeal cancer receiving cisplatin-based concurrent chemoradiotherapy. ERCC1 expression may become a molecular marker in predicting the clinical outcome of these patients.

Tumori 2014; 100(3): 328 - 332

Article Type: ORIGINAL RESEARCH ARTICLE

DOI:10.1700/1578.17218

Authors

Zhongxin Zhang, Changqing Jiang, Likuan Hu

Article History

This article is available as full text PDF.

  • If you are a Subscriber, please log in now.

  • Article price: Eur 36,00
  • You will be granted access to the article for 72 hours and you will be able to download any format (PDF or ePUB). The article will be available in your login area under "My PayPerView". You will need to register a new account (unless you already own an account with this journal), and you will be guided through our online shop. Online purchases are paid by Credit Card through PayPal.
  • If you are not a Subscriber you may:
  • Subscribe to this journal
  • Unlimited access to all our archives, 24 hour a day, every day of the week.

Authors

Article usage statistics

The blue line displays unique views in the time frame indicated.
The yellow line displays unique downloads.
Views and downloads are counted only once per session.

No supplementary material is available for this article.